Analyst Research Report Snapshot

Title:

AtriCure, Inc.

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

20 Feb 2013

Pages:

33

Type:

AcrobatPDF

Companies referenced:

ATRC.OQ

Available for Immediate Download
Summary:

AtriCure, Inc. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on AtriCure, Inc. required for business and competitor intelligence needs - Intelligence on AtriCure, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about AtriCure, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: AtriCure is a medical device company that develops, manufactures and sells cardiac surgical ablation systems, which are designed to create precise lesions or scars, in cardiac or heart tissue. The company's primary products include Isolator Synergy bipolar ablation clamp system, radio-frequency ablation devices, cryoablation system, and atriclip gillinov-cosgrove left atrial appendage system. It sells the medical devices to hospitals and medical clinics. The company operates in the US and the Netherlands. It is headquartered in West Chester, Ohio and employs around 220 people. The company recorded revenues of $59 million in the fiscal year ended December 2010, an increase of 8.2% over 2009. The company's operating loss was $3.2 million in fiscal 2010, as compared to an operating loss of $15.5 million in 2009. Its net loss was $3.8 million in fiscal 2010, as compared to the net loss of $16.5 million in 2009. Reasons to Purchase: - Gain understanding of AtriCure, Inc. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess AtriCure, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on AtriCure, Inc. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.